-
1.发明申请FORMULATION COMPRISING FENOFIBRIC ACID, A PHYSIOLOGICALLY ACCEPTABLE SALT OR DERIVATIVE THEREOF 审中-公开包含非洲酸，生理上可接受的盐或其衍生物的配方公开(公告)号：US20120178808A1
公开(公告)日：2012-07-12
申请号：US13421420
申请日：2012-03-15
IPC分类号： A61K31/216 , A61P3/06 , A61K31/192
CPC分类号： A61K31/56 , A61K9/146 , A61K9/1652 , A61K9/2054 , A61K31/192 , A61K31/205 , A61K31/216 , A61K31/495 , A61K31/58
摘要： A formulation comprising i) fenofibric acid, a physiologically acceptable salt or derivative thereof and optionally other active substances, a binder component comprising at least one enteric binder, and optionally iii) other physiologically acceptable excipients is described. Fenofibric acid, the physiologically acceptable salt or derivative thereof is preferably in the form of a molecular dispersion in these formulations. An advantageous process for their preparation, in particular by melt extrusion, and the use of this formulation for oral administration of fenofibric acid, a physiologically acceptable salt or derivative thereof are likewise described.
摘要翻译： 描述了一种制剂，其包含i）非诺贝酸，其生理学上可接受的盐或其衍生物和任选的其它活性物质，包含至少一种肠溶粘合剂和任选地iii）其它生理上可接受的赋形剂的粘合剂组分。 非诺贝酸，其生理学上可接受的盐或衍生物优选为这些制剂中分子分散体的形式。 同样描述了其制备的有利方法，特别是通过熔融挤出，以及该制剂用于口服非诺贝酸，其生理学上可接受的盐或其衍生物的用途。
-
2.发明申请Formulation Comprising Fenofibric Acid, A Physiologically Acceptable Salt or Derivative Thereof 审中-公开包含非诺贝酸，一种生理上可接受的盐或其衍生物的制剂公开(公告)号：US20100081715A1
公开(公告)日：2010-04-01
申请号：US12550378
申请日：2009-08-30
IPC分类号： A61K31/215 , A61K31/192
CPC分类号： A61K31/56 , A61K9/146 , A61K9/1652 , A61K9/2054 , A61K31/192 , A61K31/205 , A61K31/216 , A61K31/495 , A61K31/58
摘要： A formulation comprising i) fenofibric acid, a physiologically acceptable salt or derivative thereof a other active substances, ii) a binder component comprising at least one enteric binder, and optionally iii) other physiologically ceptable excipients is described. Fenofibric acid, the physiologically acceptable salt or derivative thereof is preferably in the form of a molecular dispersion in these formulations. An advantageous process for their preparation, in particular by melt extrusion, and the use of this formulation for oral administration of fenofibric acid, a physiologically acceptable salt or derivative thereof are likewise described.
摘要翻译： 一种制剂，其包含i）非诺贝酸，其生理上可接受的盐或其衍生物和其它活性物质，ii）包含至少一种肠溶粘合剂和任选地iii）其它生理上可吸取的赋形剂的粘合剂组分。 非诺贝酸，其生理学上可接受的盐或衍生物优选为这些制剂中分子分散体的形式。 同样描述了其制备的有利方法，特别是通过熔融挤出，以及该制剂用于口服非诺贝酸，其生理学上可接受的盐或其衍生物的用途。
-
3.发明申请FORMULATION COMPRISING FENOFIBRIC ACID, A PHYSIOLOGICALLY ACCEPTABLE SALT OR DERIVATIVE THEREOF 审中-公开包含非洲酸，生理上可接受的盐或其衍生物的配方公开(公告)号：US20120046360A1
公开(公告)日：2012-02-23
申请号：US13216888
申请日：2011-08-24
IPC分类号： A61K31/216 , A61P3/06 , A61K31/192
CPC分类号： A61K31/56 , A61K9/146 , A61K9/1652 , A61K9/2054 , A61K31/192 , A61K31/205 , A61K31/216 , A61K31/495 , A61K31/58
摘要： A formulation comprising i) fenofibric acid, a physiologically acceptable salt or derivative thereof and optionally other active substances, ii) a binder component comprising at least one enteric binder, and optionally iii) other physiologically acceptable excipients is described. Fenofibric acid, the physiologically acceptable salt or derivative thereof is preferably in the form of a molecular dispersion in these formulations. An advantageous process for their preparation, in particular by melt extrusion, and the use of this formulation for oral administration of fenofibric acid, a physiologically acceptable salt or derivative thereof are likewise described.
摘要翻译： 包含i）非诺贝酸，其生理学上可接受的盐或其衍生物和任选的其它活性物质的制剂，ii）包含至少一种肠溶粘合剂和任选地iii）其它生理上可接受的赋形剂的粘合剂组分。 非诺贝酸，其生理学上可接受的盐或衍生物优选为这些制剂中分子分散体的形式。 同样描述了其制备的有利方法，特别是通过熔融挤出，以及该制剂用于口服非诺贝酸，其生理学上可接受的盐或其衍生物的用途。
-
-
搜索结果
3 条记录 (耗时 0.023 秒)
